Plain-English translation of NCT06325046 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer, shorter radiation therapy approach works as well as the standard treatment for early prostate cancer. You would receive focused radiation beams aimed directly at your prostate to destroy cancer cells. The study compares two different schedules: finishing treatment in just 2 sessions versus the standard 5 sessions, and measures how each affects your quality of life and any side effects.
Standard prostate cancer radiation therapy typically requires 5 treatment sessions, which is time-consuming and can be difficult for patients to manage. Doctors want to know if a shorter 2-session approach could work just as well while reducing the burden on patients and potentially causing fewer side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either 2 radiation treatments (at least 3 days apart) or 5 radiation treatments (at least 2 days apart). Before and during treatment, you will have imaging scans to precisely target your cancer. You will complete questionnaires about your urinary and bowel function, erectile function, and quality of life at multiple time points over 5 years, and your doctors will monitor you for any side effects.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States